Expand ARMP Menu
ARMP MENU

ARMP Latest Press Releases

-- January 13, 2026 --

/C O R R E C T I O N -- Armata Pharmaceuticals, Inc./ PRNewswire 7:42 AM
Armata Pharmaceuticals Announces End-of-Phase 2 Meeting with FDA and Plans to Advance AP-SA02 to a Phase 3 Superiority Study in Complicated BacteremiaStaphylococcusaureus PRNewswire 7:00 AM

-- November 18, 2025 --

Armata Pharmaceuticals Announces Key Opinion Leader Webinar on S. aureus Bacteremia and AP-SA02 Hosted by Jones Research on November 25th at 10:00am EST PRNewswire 7:00 AM

-- November 12, 2025 --

Armata Pharmaceuticals Announces Third Quarter 2025 Results and Provides Corporate Update PRNewswire 4:05 PM

-- November 10, 2025 --

Armata Pharmaceuticals Announces Formal Commissioning of State-of-the-Art cGMP Phage Manufacturing Facility in Los Angeles, California PRNewswire 7:00 AM

-- October 28, 2025 --

Could the Next Breakthrough in Antibiotic Resistance Come From Viruses That Kill Bacteria? AB Digital Inc 3:29 PM

-- October 22, 2025 --

Armata Pharmaceuticals Highlights Positive Results from Phase 2a diSArm Study of its Staphylococcus aureus Bacteriophage Cocktail, AP-SA02, in Late-Breaking Oral Presentation at IDWeek 2025 PRNewswire 11:10 AM

-- October 14, 2025 --

Armata Pharmaceuticals to Present Late-Breaking Clinical Data highlighting its Staphylococcus aureus Bacteriophage Cocktail, AP-SA02, at IDWeek 2025 PRNewswire 7:01 AM

-- September 8, 2025 --

Armata Pharmaceuticals Announces Structural Biology Publication in the Journal of Molecular Biology PRNewswire 7:00 AM

-- September 4, 2025 --

Armata Pharmaceuticals to Participate in the H.C. Wainwright 27th Annual Global Investment Conference PRNewswire 7:00 AM
Market Data Delayed 15 Minutes